|
RFWD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.55790000000123E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.957750E-04 |
| Normal-vs-Stage2 |
1.095960E-02 |
| Normal-vs-Stage3 |
7.104500E-03 |
| Normal-vs-Stage4 |
5.66679999999264E-05 |
| Stage1-vs-Stage2 |
9.626800E-01 |
| Stage1-vs-Stage3 |
5.437600E-01 |
| Stage1-vs-Stage4 |
2.023000E-01 |
| Stage2-vs-Stage3 |
6.604400E-01 |
| Stage2-vs-Stage4 |
3.306000E-01 |
| Stage3-vs-Stage4 |
1.130150E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.209300E-04 |
| Normal-vs-AfricanAmerican |
5.609000E-01 |
| Normal-vs-Asian |
9.036700E-04 |
| Caucasian-vs-AfricanAmerican |
1.077620E-01 |
| Caucasian-vs-Asian |
6.870800E-01 |
| AfricanAmerican-vs-Asian |
4.216000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.306200E-02 |
| Normal-vs-Female |
2.13929999999252E-05 |
| Male-vs-Female |
6.624400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.779600E-04 |
| Normal-vs-Age(41-60Yrs) |
8.00340000000066E-05 |
| Normal-vs-Age(61-80Yrs) |
5.461800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.851000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.573600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.030600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.292200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.610800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.823600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.174400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.089800E-01 |
| Classical-VS-Follicular |
1.547980E-02 |
| Classical-VS-Other |
6.939600E-01 |
| Classical-VS-Normal |
7.761700E-03 |
| Tall-VS-Follicular |
9.122000E-02 |
| Tall-VS-Other |
6.251200E-01 |
| Tall-VS-Normal |
1.231590E-01 |
| Follicular-VS-Other |
6.497600E-01 |
| Follicular-VS-Normal |
5.56259999999753E-05 |
| Other-VS-Normal |
3.065800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.5207699999964E-05 |
| Normal-vs-N1 |
4.42800000000076E-05 |
| N0-vs-N1 |
4.369000E-01 |
|
|
